Recce Pharmaceuticals Ltd.ASX: RCE

AUD $5.3m R&D Rebate Received

· Issued by Recce Pharmaceuticals Ltd.

Filed with ASX · · 2 pages · English

Summary by 6ix AI

The rebate reflects R&D activities conducted both locally and internationally, providing the company with non-dilutive funding for its ongoing clinical trials and development programs. The CEO emphasized that this funding will bolster their R&D efforts, particularly in combating antibiotic-resistant infections.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

Recce Pharmaceuticals Ltd. on 6ix

Story so far

Earlier from Recce Pharmaceuticals

Later from Recce Pharmaceuticals

All Recce Pharmaceuticals news releases